LiverRight and Aegle Medical Solutions, LLC have announced a strategic partnership aimed at expanding access to non-invasive liver assessment, specialist interpretation, diagnosis, and ongoing liver care for patients across the United States. The collaboration brings together Aegle Medical's advanced liver assessment technology and implementation support with LiverRight's national virtual liver clinic, creating a more connected pathway from liver disease identification to long-term management.
For physicians, health systems, and independent practices, the partnership offers a way to establish or expand comprehensive liver disease programs without building every component internally. Aegle Medical provides a consultative approach to technology evaluation, implementation, training, and ongoing support, including the Mindray Hepatus-Series Transient Elastography Diagnostic Ultrasound Systems. LiverRight complements this with same-day interpretation services for liver elastography studies and same-week virtual access to its hepatology clinicians. Its Liververse™ referral system coordinates bloodwork, patient-reported outcomes, imaging, diagnosis, and longitudinal disease management.
The partnership's significance lies in its potential to address the large number of adults living with undiagnosed liver disease in the U.S. By bringing advanced liver assessment into outpatient settings and providing timely specialist interpretation, the model aims to move patients more efficiently into appropriate diagnostic and care workflows. Brandon Tudor, CEO of LiverRight, noted that Aegle Medical is helping hospital systems and independent practices nationwide tackle this issue, and by working together, they can help practices bring advanced liver assessment into the outpatient setting, provide timely specialist interpretation, and move patients into the appropriate diagnostic and care workflow with greater efficiency.
Michael McTighe, President & CEO of Aegle Medical Solutions, emphasized that the partnership represents an important step forward in expanding access to liver disease detection and care within communities. He stated that by connecting Aegle Medical's capabilities with LiverRight's nationwide virtual liver-care network and same-day interpretation services, customers receive more than technology—they gain a more complete pathway from assessment to diagnosis and ongoing patient management. McTighe added that this model can be particularly valuable for communities where access to hepatology specialists may be limited, with the goal of helping providers identify liver disease earlier, improve access to specialist expertise, and create a better experience for both patients and clinicians.
A key technological component of the partnership is the Mindray Hepatus platform, which introduces Visualized Transient Elastography (ViTE), a next-generation advancement beyond conventional transient elastography. Unlike legacy platforms that rely primarily on measurement data without real-time anatomical visualization, ViTE integrates real-time B-mode ultrasound visualization directly into the elastography examination. This allows operators to see liver anatomy, identify the optimal measurement location, and visually guide each acquisition while obtaining quantitative liver stiffness and attenuation measurements. The Hepatus platform provides liver stiffness measurement (LSM) for fibrosis assessment and Liver UltraSound Attenuation (LiSA) for quantitative assessment of hepatic steatosis. The Hepatus 6 further expands capabilities with diagnostic ultrasound imaging, including abdominal imaging, Doppler, spleen stiffness assessment, and intestinal ultrasound, depending on configuration.
LiverRight has its own hepatologists and hepatology advanced practice providers licensed across all 50 U.S. states, supporting adult patients with conditions such as MASLD/MASH, alcohol-associated liver disease, hepatitis B and C, primary biliary cholangitis, primary sclerosing cholangitis, autoimmune hepatitis, and liver cancer diagnosis. The strategic relationship gives health systems, GI and hepatology practices, and independent providers a scalable approach to expanding liver services under their own brand. By combining advanced non-invasive liver assessment technology, implementation and clinical support, timely specialist interpretation, and a pathway to continued liver care, the partnership aims to improve early detection and management of liver disease while enhancing patient and clinician experiences.
